Leo Pharma struggles with lawsuit in the US
In the US State of New York, Leo Pharma may be subjected to a class-action lawsuit over the firm's drug Picato, which was taken off the market last year.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
In the US, it looks like a new major lawsuit will revolve around Leo Pharma's drug Picato, according to Bloomberg Law.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
MC2 Therapeutics aims to lead psoriasis market
For subscribers
